Lilly Launches Higher Dose Vials of Weight-Loss Drug for $150 Less Than Injector Pen
(Reuters) - Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in ...
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower ...
What is metformin, the old diabetes drug some people are taking for weight loss?
The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...
cnbctv1820m
USFDA asks Dr Reddy's to sort out issues at its Hyderabad facility
Dr Reddy's Laboratories Ltd said on February 25 that the American drugs regulator finished inspecting its API manufacturing ...
pharmaphorum19m
Pharma's AI is missing the "Why”
For any company developing AI-powered solutions, the “why” should guide every decision. The technical sophistication of your ...
BusinessMirror24m
Group to online shopping platforms: Take down FDA-banned cosmetics ads, promos
THE toxics watchdog BAN Toxics on Tuesday urged social media and online shopping platforms to take down content, advertisements, and listings promoting mercury-tainted skin-lightening products banned ...
Hosted on MSN2m
Nvidia Can Halt Tech Stocks’ Slump and Save the Market Rally, Or End It. And 5 Other Things to Know Today.
Hims ended 2024 with 2.2 million subscribers.The company has been positioning its brand messaging as an alternative to the ...
Ex-Stanford research coordinator convicted of tampering with cancer study database
A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.